Literature DB >> 26192015

Penultimate proline in neuropeptides.

Matthew S Glover1, Earl P Bellinger1, Predrag Radivojac1, David E Clemmer1.   

Abstract

A recent ion mobility spectrometry-mass spectrometry (IMS-MS) study revealed that tryptic peptide ions containing a proline residue at the second position from the N-terminus (i.e., penultimate proline) frequently adopt multiple conformations, owing to the cis-trans isomerization of Xaa(1)-Pro(2) peptide bonds [J. Am. Soc. Mass Spectrom. 2015, 26, 444]. Here, we present a statistical analysis of a neuropeptide database that illustrates penultimate proline residues are frequently found in neuropeptides. In order to probe the effect of penultimate proline on neuropeptide conformations, IMS-MS experiments were performed on two model peptides in which penultimate proline residues were known to be important for biological activity: the N-terminal region of human neuropeptide Y (NPY1-9, Tyr(1)-Pro(2)-Ser(3)-Lys(4)-Pro(5)-Asp(6)-Asn(7)-Pro(8)-Gly(9)-NH2) and a tachykinin-related peptide (CabTRP Ia, Ala(1)-Pro(2)-Ser(3)-Gly(4)-Phe(5)-Leu(6)-Gly(7)-Met(8)-Arg(9)-NH2). From these studies, it appears that penultimate prolines allow neuropeptides to populate multiple conformations arising from the cis-trans isomerization of Xaa(1)-Pro(2) peptide bonds. Although it is commonly proposed that the role of penultimate proline residues is to protect peptides from enzymatic degradation, the present results indicate that penultimate proline residues also are an important means of increasing the conformational heterogeneity of neuropeptides.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26192015     DOI: 10.1021/acs.analchem.5b01889

Source DB:  PubMed          Journal:  Anal Chem        ISSN: 0003-2700            Impact factor:   6.986


  8 in total

1.  Fundamentals of Trapped Ion Mobility Spectrometry Part II: Fluid Dynamics.

Authors:  Joshua A Silveira; Karsten Michelmann; Mark E Ridgeway; Melvin A Park
Journal:  J Am Soc Mass Spectrom       Date:  2016-02-10       Impact factor: 3.109

2.  Multiple gas-phase conformations of proline-containing peptides: is it always cis/trans isomerization?

Authors:  Christopher B Lietz; Zhengwei Chen; Chang Yun Son; Xueqin Pang; Qiang Cui; Lingjun Li
Journal:  Analyst       Date:  2016-08-02       Impact factor: 4.616

3.  Cis→Trans Isomerization of Pro(7) in Oxytocin Regulates Zn(2+) Binding.

Authors:  Daniel R Fuller; Matthew S Glover; Nicholas A Pierson; DoYong Kim; David H Russell; David E Clemmer
Journal:  J Am Soc Mass Spectrom       Date:  2016-05-06       Impact factor: 3.109

4.  Substance P in Solution: Trans-to-Cis Configurational Changes of Penultimate Prolines Initiate Non-enzymatic Peptide Bond Cleavages.

Authors:  Christopher R Conant; Daniel R Fuller; Tarick J El-Baba; Zhichao Zhang; David H Russell; David E Clemmer
Journal:  J Am Soc Mass Spectrom       Date:  2019-04-12       Impact factor: 3.109

5.  Substance P in the Gas Phase: Conformational Changes and Dissociations Induced by Collisional Activation in a Drift Tube.

Authors:  Christopher R Conant; Daniel R Fuller; Zhichao Zhang; Daniel W Woodall; David H Russell; David E Clemmer
Journal:  J Am Soc Mass Spectrom       Date:  2019-04-12       Impact factor: 3.109

Review 6.  Recent advances in mass spectrometry analysis of neuropeptides.

Authors:  Ashley Phetsanthad; Nhu Q Vu; Qing Yu; Amanda R Buchberger; Zhengwei Chen; Caitlin Keller; Lingjun Li
Journal:  Mass Spectrom Rev       Date:  2021-09-24       Impact factor: 9.011

7.  Novel polysaccharide binding to the N-terminal tail of galectin-3 is likely modulated by proline isomerization.

Authors:  Michelle C Miller; Y Zheng; Jingmin Yan; Yifa Zhou; Guihua Tai; Kevin H Mayo
Journal:  Glycobiology       Date:  2017-11-01       Impact factor: 4.313

Review 8.  New techniques, applications and perspectives in neuropeptide research.

Authors:  Kellen DeLaney; Amanda R Buchberger; Louise Atkinson; Stefan Gründer; Angela Mousley; Lingjun Li
Journal:  J Exp Biol       Date:  2018-02-08       Impact factor: 3.312

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.